» Articles » PMID: 27812489

Plasmid-Mediated Quinolone-Resistance () Genes in Clinical Isolates of Collected from Several Hospitals of Qazvin and Zanjan Provinces, Iran

Overview
Specialty Public Health
Date 2016 Nov 5
PMID 27812489
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: is regarded as the most important etiological agent of urinary tract infections. Fluoroquinolones are routinely used in the treatment of these infections; however, in recent years, a growing rate of resistance to these drugs has been reported globally. The aims of this study were to detect plasmid-mediated , , and genes among the quinolone-nonsusceptible isolates and to investigate their clonal relatedness in Qazvin and Zanjan Provinces, Iran.

Methods: A total of 200 clinical isolates of were collected from hospitalized patients. The bacterial isolates were identified through standard laboratory protocols and further confirmed using API 20E test strips. Antimicrobial susceptibility was determined by the standard disk diffusion method. Polymerase chain reaction (PCR) and sequencing were used for detecting , , and genes and the clonal relatedness of -positive isolates was evaluated by enterobacterial repetitive intergenic consensus-PCR (ERIC-PCR) method.

Results: In total, 136 (68%) isolates were nonsusceptible to quinolone compounds, among which 45 (33.1%) and 71 (52.2%) isolates showed high- and low-level quinolone resistance, respectively. Of the 136 isolates, four (2.9%) isolates were positive for the gene. The results from ERIC-PCR revealed that two (50%) cases of -positive isolates were related genetically.

Conclusion: Our study results were indicative of the presence of low frequency of genes among the clinical isolates of in Qazvin and Zanjan Provinces, which emphasizes the need for establishing tactful policies associated with infection-control measures in our hospital settings.

Citing Articles

Biofilm Formation and Plasmid-Mediated Quinolone Resistance Genes at Varying Quinolone Inhibitory Concentrations in Quinolone-Resistant Bacteria Superinfecting COVID-19 Inpatients.

Basnet A, Chand A, Bajracharya S, Shrestha M, Shrestha S, Tamang B Am J Trop Med Hyg. 2024; 112(2):346-354.

PMID: 39561392 PMC: 11803653. DOI: 10.4269/ajtmh.24-0276.


Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation.

Kherroubi L, Bacon J, Rahman K JAC Antimicrob Resist. 2024; 6(4):dlae127.

PMID: 39144447 PMC: 11323783. DOI: 10.1093/jacamr/dlae127.


A review of the mechanisms that confer antibiotic resistance in pathotypes of .

Nasrollahian S, Graham J, Halaji M Front Cell Infect Microbiol. 2024; 14:1387497.

PMID: 38638826 PMC: 11024256. DOI: 10.3389/fcimb.2024.1387497.


Phylogenetic analysis, biofilm formation, antimicrobial resistance and relationship between these characteristics in Uropathogenic Escherichia coli.

Talieh Mostaghimi , Pournajaf A, Bijani A, Mohammadi M, Rajabnia M, Halaji M Mol Biol Rep. 2024; 51(1):327.

PMID: 38393446 DOI: 10.1007/s11033-023-09031-x.


Quinolone resistance and biofilm formation capability of uropathogenic Escherichia coli isolates from an Iranian inpatients' population.

Rastegar E, Malekzadegan Y, Khashei R, Hadi N Mol Biol Rep. 2023; 50(10):8073-8079.

PMID: 37540453 DOI: 10.1007/s11033-023-08704-x.


References
1.
Strahilevitz J, Jacoby G, Hooper D, Robicsek A . Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 2009; 22(4):664-89. PMC: 2772364. DOI: 10.1128/CMR.00016-09. View

2.
Smith J, Drum D, Dai Y, Kim J, Sanchez S, Maurer J . Impact of antimicrobial usage on antimicrobial resistance in commensal Escherichia coli strains colonizing broiler chickens. Appl Environ Microbiol. 2006; 73(5):1404-14. PMC: 1828781. DOI: 10.1128/AEM.01193-06. View

3.
Kim H, Park C, Kim C, Kim E, Jacoby G, Hooper D . Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother. 2008; 53(2):639-45. PMC: 2630623. DOI: 10.1128/AAC.01051-08. View

4.
Deepak R, Koh T, Chan K . Plasmid-mediated quinolone resistance determinants in urinary isolates of Escherichia coli and Klebsiella pneumoniae in a large Singapore hospital. Ann Acad Med Singap. 2010; 38(12):1070-3. View

5.
Mammeri H, Van De Loo M, Poirel L, Martinez-Martinez L, Nordmann P . Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother. 2004; 49(1):71-6. PMC: 538905. DOI: 10.1128/AAC.49.1.71-76.2005. View